| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 3 | +1.76 M | 100% | $0.76 | +$1.34 M |
| Sells | 0 | ||||
| Net | +3 | +1.76 M | 100% | +$1.34 M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Stuart M. Grant | 10%+ Owner | $7.2 M | +$1.32 M | +22.4% | Jul 2, 2024 |
| Fredric N. Eshelman | Director | $1.77 M | Nov 17, 2021 | ||
| Tsontcho Ianchulev | Director | $1.39 M | Jun 12, 2024 | ||
| Ernest Mario | Director | $520 K | Nov 17, 2021 | ||
| Charles E. Mather IV | Director | $213 K | Jun 12, 2024 | ||
| Ellen R. Strahlman | Director | $186 K | +$8.1 K | +4.56% | Jun 12, 2024 |
| Rachel Jacobson | Director | $142 K | Jun 12, 2024 | ||
| Ram Palanki | Director | $135 K | Jun 12, 2024 | ||
| Jennifer Clasby | VP, Regulatory and Clinical | $124 K | Jun 17, 2021 | ||
| Michael Geltzeiler | Director | $111 K | Jun 12, 2024 | ||
| Kenneth B. Lee Jr | Director | $87.8 K | Jun 16, 2022 | ||
| Curt H. LaBelle | Director | $57.4 K | Nov 17, 2021 | ||
| Michael Rowe | Chief Executive Officer, Director | $44.8 K | +$11 K | +32.4% | Feb 12, 2024 |
| Julia A. Haller | Director | $41.4 K | Jun 16, 2022 | ||
| Anthony Y. Sun | Director | $35.8 K | Nov 17, 2021 | ||
| Stephen Keith Benjamin | Director | $34.7 K | Jun 16, 2022 | ||
| John P. Gandolfo | Chief Financial Officer | $10.9 K | Feb 12, 2024 | ||
| Bren Kern | Chief Operating Officer | $3.4 K | Feb 12, 2024 | ||
| Luke Clauson | VP Research & Development | Jun 16, 2021 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|